]>
IRCT20191112045426N1 IRCT 2020-01-07 Qazvin University of Medical Sciences Effect of intravenous vitamin c in decreasing ferritin level in patients with ESRD under dialysis Effect of intravenous vitamin c in decreasing ferritin level in patients with ESRD under dialysis 2020-04-11 anticipated 32 Complete https://irct.ir/trial/44379 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The sampling is done in an available way. Patients were randomly divided into intervention group A and control B using Winpepi software By a methodologist, Blinding description: As the intervention prescribed by the researchers is injected by the project executive, in addition to the patients who administer the intervention and evaluate the results, they are also blind to the type of intervention administered, so the study will be a triple-blind study. 3 Chronic kidney disease (CKD). Intervention 1: Intervention group: The intervention group received intravenous ascorbic acid 500 mg three times a week after each dialysis session for 3 months with erythropoietin IV. Intervention 2: Control group: The control group received distilled water as placebo three times a week after each hemodialysis for 3 months and erythropoietin IV. Yes - There is a plan to make this available What will be shared: The results of this research will be shared after the end of the research. When: The results of this research will be shared after the end of the research. To whom: Medical universities will have access to the documentation. Conditions: For use in treating patients Where to obtain: Qazvin University of Medical Sciences How to obtain: Send your request to Qazvin University of Medical Sciences Medical School and it will be answered after review. Comments:
public Mohammad Taheri
Saadat Blv
Qazvin Iran (Islamic Republic of) 3415766858 +98 28 3368 1570 m.t.a.h.e.r.i@yandex.com Qazvin University of Medical Sciences scientific Mohammad Taheri
Saadat Blv
Qazvin Iran (Islamic Republic of) 3415766858 +98 28 3368 1570 m.t.a.h.e.r.i@yandex.com Qazvin University of Medical Sciences Iran (Islamic Republic of) Patients undergoing hemodialysis with iron deficiency anemia with Hb <11 g / dl and serum ferritin level (> 500 ng / ml) and transferrin saturation (TSAT ≤ 20%) no limit no limit Both D63.1 Anemia in chronic kidney disease Treatment - Drugs Placebo Intervention group: The intervention group received intravenous ascorbic acid 500 mg three times a week after each dialysis session for 3 months with erythropoietin IV. Control group: The control group received distilled water as placebo three times a week after each hemodialysis for 3 months and erythropoietin IV. Age. Timepoint: before intervention. Method of measurement: Form. Gender. Timepoint: before intervention. Method of measurement: Form. Marital status. Timepoint: before intervention. Method of measurement: Form. Serum ferritin level. Timepoint: before intervention and after three months. Method of measurement: Paraclinic. Hemoglobin. Timepoint: before intervention and after three months. Method of measurement: Paraclinic. TIBC(Total Iron binding capacity ). Timepoint: before intervention and after three months. Method of measurement: Paraclinic. Transferrin saturation. Timepoint: before intervention and after three months. Method of measurement: Paraclinic. Intervention group. Timepoint: before intervention and after three months. Method of measurement: software. researchers Approved 2019-12-30 Ethics committee of Qazvin University of Medical Sciences Shahid Beheshti, Ave' 3415613911 Qazvin' IRAN Qazvin Qazvin Iran (Islamic Republic of)